Associated Papers
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression.
Lheureux S et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2023
37327320 (PubMed )
Supplement: ccr-23-0797_supplementary_table_s5_suppts5.xlsx › Supplementary_Table_S5
A novel molecular diagnostics platform for somatic and germline precision oncology.
Cabanillas R et al.
Molecular Genetics & Genomic Medicine, 2017
Exploring the roles of PALB2 at the crossroads of DNA repair and cancer.
Pauty J et al.
The Biochemical Journal, 2014
Select a paper to view details